Pattern of joint involvement and other disease characteristics in 634 patients with arthritis of less than 16 weeks' duration

Journal of Rheumatology

Volumn 36, Issue 7, 2009, Pages 1401-1406

  Mjaavatten, Maria Dahl ^a   Haugen, Anne Julsrud ^b   Helgetveit, Knut ^c   Nygaard, Halvor ^d   Sidenvall, Göran ^e   Uhlig, Till ^a   Kvien, Tore Kristian ^a,f  

^a DIAKONHJEMMET HOSPITAL   (Norway)

^b Ostfold Hospital   (Norway)

^c MARTINA HANSENS HOSPITAL   (Norway)

^d Hospital for Rheumatic Diseases   (Norway)

^e Innlandet Hospital   (Norway)

^f UNIVERSITY OF OSLO   (Norway)

Author keywords

Arthritis; Consultation; Epidemiology; Referral; Registries; Synovitis

Indexed keywords

ACUTE PHASE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

ADULT; AGED; ANKLE ARTHRITIS; ANKLE INJURY; ARTHRITIS; ARTHROPATHY; ARTICLE; CLINICAL TRIAL; DISEASE DURATION; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; KNEE ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MONARTHRITIS; MULTICENTER STUDY; NORWAY; PAIN ASSESSMENT; POLYARTHRITIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; AMBULATORY CARE FACILITIES; ANTIRHEUMATIC AGENTS; ARTHRITIS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; JOINTS; MALE; MIDDLE AGED; NORWAY; PAIN MEASUREMENT; TIME FACTORS;

EID: 67650499600     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.081217     Document Type: Article

References (34)

1. Kellgren JH, Lawrence JS. Rheumatoid arthritis in a population sample. Ann Rheum Dis 1956;15:1-11.
2. Mikkelsen WM, Dodge H. A four year follow-up of suspected rheumatoid arthritis: the Tecumseh, Michigan, Community Health Study. Arthritis Rheum 1969;12:87-91.
3. Pincus T, Callahan LF. What is the natural history of rheumatoid arthritis? Rheum Dis Clin North Am 1993;19:123-51.
4. Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology 2004;43:906-14.
5. van Dongen H, van Aken J, Lard LR, et al. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2007;56:1424-32.
6. Soderlin MK, Börjesson O, Kautiainen H, Skogh T, Leirisalo-Repo M. Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann Rheum Dis 2002;61:911-5.
7. Savolainen E, Kaipiainen-Seppänen O, Kröger L, Luosujärvi R. Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey. J Rheumatol 2003;30:2460-8.
8. Zirkzee EJ, Sneep AC, de Buck PD, et al. Sick leave and work disability in patients with early arthritis. Clin Rheumatol 2008;27:11-9.
9. Bukhari M, Lunt M, Barton A, Bunn D, Silman A, Symmons D. Increasing age at symptom onset is associated with worse radiological damage at presentation in patients with early inflammatory polyarthritis. Ann Rheum Dis 2007;66:389-93.
10. Harrison BJ, Symmons DP, Brennan P, et al. Inflammatory polyarthritis in the community is not a benign disease: predicting functional disability one year after presentation. J Rheumatol 1996;23:1326-31.
11. Jansen LM, van Schaardenburg D, van der Horst-Bruinsma IE, Dijkmans BA. One year outcome of undifferentiated polyarthritis. Ann Rheum Dis 2002;61:700-3.
12. Machold KP, Stamm TA, Nell VP, et al. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. Rheumatology 2007;46:342-9.
13. Kvien TK, Glennås A, Melby K, et al. Reactive arthritis: incidence, triggering agents and clinical presentation. J Rheumatol 1994;21:115-22.
14. Quinn MA, Green MJ, Marzo-Ortega H, et al. Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol. Arthritis Rheum 2003;48:3039-45.
15. Egsmose C, Hansen TM, Andersen LS, et al. Limited effect of sulphasalazine treatment in reactive arthritis. A randomised double blind placebo controlled trial. Ann Rheum Dis 1997;56:32-6.
16. Marzo-Ortega H, Green MJ, Keenan AM, Wakefield RJ, Proudman S, Emery P. A randomized controlled trial of early intervention with intraarticular corticosteroids followed by sulfasalazine versus conservative treatment in early oligoarthritis. Arthritis Rheum 2007;57:154-60.
17. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual Life Outcomes 2003;1:20.
18. Loge JH, Kaasa S, Hjermstad MJ, Kvien TK. Translation and performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability, and construct validity. J Clin Epidemiol 1998;51:1069-76.
19. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
20. Stucki G, Liang MH, Stucki S, Bruhlmann P, Michel BA. A self-administered Rheumatoid Arthritis Disease Activity Index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity. Arthritis Rheum 1995;38:795-8.
21. Jonsson T, Arnason JA, Valdimarsson H. Enzyme-linked immunosorbent assay (ELISA) screening test for detection of rheumatoid factor. Rheumatol Int 1986;6:199-204.
22. van der Helm-van Mil AH, le Cessie S, van Dongen H, Breedveld FC, Toes RE, Huizinga TW. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum 2007;56:433-40.
23. van der Helm-van Mil AH, Detert J, le Cessie S, et al. Validation of a prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: moving toward individualized treatment decision-making. Arthritis Rheum 2008;58:2241-7.
24. Kuriya B, Cheng CK, Chen HM, Bykerk VP. Validation of a prediction rule for development of rheumatoid arthritis in patients with early undifferentiated arthritis. Ann Rheum Dis 2008; E-pub ahead of print November 17.
25. Symmons D, Harrison B. Early inflammatory polyarthritis: results from the Norfolk Arthritis Register with a review of the literature. I. Risk factors for the development of inflammatory polyarthritis and rheumatoid arthritis. Rheumatology 2000;39:835-43.
26. van der Horst-Bruinsma IE, Speyer I, Visser H, Breedveld FC, Hazes JM. Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care. Br J Rheumatol 1998;37:1084-8.
27. Kvien TK, Glennås A, Melby K. Prediction of diagnosis in acute and subacute oligoarthritis of unknown origin. Br J Rheumatol 1996;35:359-63.
28. Syversen SW, Gaarder PI, Goll GL, et al. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis 2008;67:212-7.
29. Syversen SW, Goll GL, van der Heijde D, et al. Cartilage and bone biomarkers in rheumatoid arthritis: Prediction of 10-year radiographic progression. J Rheumatol 2008;36:266-72.
30. Mjaavatten MD, Nygaard H, Haugen AJ, Sidenvall G, Helgetveit K, Kvien TK. Baseline predictors of persistent arthritis, DMARD start and rheumatoid arthritis diagnosis: one year follow-up of 395 patients with very early arthritis [abstract]. Arthritis Rheum 2008;58 Suppl:S437.
31. Fleming A, Crown JM, Corbett M. Prognostic value of early features in rheumatoid disease. Br Med J 1976;1:1243-5.
32. Linn-Rasker SP, van der Helm-van Mil AH, Breedveld FC, Huizinga TW. Arthritis of the large joints - in particular, the knee - at first presentation is predictive for a high level of radiological destruction of the small joints in rheumatoid arthritis. Ann Rheum Dis 2007;66:646-50.
33. Verpoort KN, van Dongen H, Allaart CF, Toes RE, Breedveld FC, Huizinga TW. Undifferentiated arthritis - disease course assessed in several inception cohorts. Clin Exp Rheumatol 2004;22:S12-7.
34. Veldi T, Mjaavatten MD, Kiviväli A, Üprus M, Otsa K, Kvien TK. Very early arthritis (less than 12 weeks duration) in Norwegian and Estonian patients: Comparison of disease characteristics and 24-week disease course in two early arthritis clinics [abstract]. Ann Rheum Dis 2007;66 Suppl:253.